Glossary entry (derived from question below)
Chinese term or phrase:
申报新功能
English translation:
Declaring of new function
Added to glossary by
billychang
Sep 15, 2005 23:20
18 yrs ago
Chinese term
Twinpens (X)
申报新功能
Chinese to English
Science
Nutrition
申报建议中的一个项目:
申报新功能.
专家意见:表中实验内容为申报新功能所需要的, ...完成这些实验内容申报新功能的机会就大一些,...
I have been engaged in biomedical research for two decades but have no idea about the "申报新功能". Please advise me.
Thank you.
申报新功能.
专家意见:表中实验内容为申报新功能所需要的, ...完成这些实验内容申报新功能的机会就大一些,...
I have been engaged in biomedical research for two decades but have no idea about the "申报新功能". Please advise me.
Thank you.
Proposed translations
(English)
| 3 +3 | Declaring of new function. |
billychang
|
| 3 +2 | filing for new medical applications for existing drugs |
wherestip
|
Proposed translations
+3
1 hr
billychang
Native in Chinese
&
English
Translate tradition & simplified Chinese
Native in: English 
, Chinese
Works in: Chinese to English, English to Chinese
Related KudoZ points
:
2
Chinese term (edited):
�걨�¹���
Selected
Declaring of new function.
..
Peer comment(s):
| agree |
Chinoise
1 min
|
|
thanks
|
|
| agree |
wherestip
9 hrs
|
|
thanks
|
|
| agree |
Denyce Seow
: declaration of new functions
9 hrs
|
|
thanks
|
2 KudoZ points awarded for this answer.
Comment: "Thank you all."
+2
10 hrs
Chinese term (edited):
�걨�¹���
filing for new medical applications for existing drugs
BTW, I have no idea what the regulation practice in the US is regarding this
http://www.forces.org/evidence/pharma/bigpharma.htm
In addition to licensing new drugs to market, the big drug companies are also focusing on developing "me too" drugs (products almost identical to drugs already on the market), finding new medical applications for existing drugs, and marketing "new" formulations of older drugs. But all of these require little investment in basic research. In fact, they are more akin to new marketing tools than anything else, despite the clinical testing that must be conducted for FDA approval.
http://www.forces.org/evidence/pharma/bigpharma.htm
In addition to licensing new drugs to market, the big drug companies are also focusing on developing "me too" drugs (products almost identical to drugs already on the market), finding new medical applications for existing drugs, and marketing "new" formulations of older drugs. But all of these require little investment in basic research. In fact, they are more akin to new marketing tools than anything else, despite the clinical testing that must be conducted for FDA approval.
Discussion